Competing-risk analyses showed prior malignancy independently increased second-cancer risk in PV/ET, even after adjusting for ...

Learn the environmental, dietary, and lifestyle factors that can lead to a PV flare-up.

Rusfertide has received orphan drug, fast track, and breakthrough therapy designations from the FDA, and in this interview, Andrew Kuykendall, MD, Moffitt Cancer Center, emphasizes the critical need ...

Learn ways to manage the itching that's a common symptom of this blood cancer.

Rusfertide, a hepcidin-mimetic peptide, reduces excess red blood cell production in polycythemia vera, addressing complications like blood clots and fatigue. The FDA granted rusfertide breakthrough ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Sleep is very important for physical and mental well-being. But disrupted sleep is a common problem in polycythemia vera (PV), a rare blood cancer in which your bone marrow makes too many red blood ...

Please provide your email address to receive an email when new articles are posted on . The data was reviewed at the 14th International Congress on Myeloproliferative Neoplasms. “These patients that ...